 platform at the upcoming American Society of Human Genetics (ASHG) 2025 Annual Meeting, October 14–18 in Boston.){kind=link}
Atrandi Biosciences, will present recent developments in its patented Semi-Permeable Capsule (SPC) platform at the upcoming American Society of Human Genetics (ASHG) 2025 Annual Meeting, October 14–18 in Boston. The company’s latest work highlights the growing potential of SPC-based methods to expand the scope of single-cell multiomic research.
The Power of Simultaneous Single-Cell RNA and Genomic DNA Sequencing in CRISPR Experiments
- Capsule-based Genome Sequencing and Lineage Tracing. Sanjay Srivatsan, PhD, Fred Hutch Cancer Center
- The Power of Simultaneous Single-Cell RNA and Genomic DNA Sequencing in CRISPR Experiments. Yuriy Baglaenko, PhD, Cincinnati Children’s Hospital Medical Center
- A Scalable Platform for Single-Cell Co-Profiling of the Transcriptome and Genotype. Rapolas Žilionis, PhD, Atrandi Biosciences
Date / Time: Wednesday, Oct. 15, 3:00 pm – 4:00 pm ET
Location: Room 204AB, Thomas M. Menino Convention & Exhibition Center, Boston
Advance Registration: Seating is limited. Learn more about the session and reserve your seat here.
The Atrandi Biosciences team is looking forward to sharing with the ASHG community the progress we and our collaborators have made in single-cell multiomics. Our proprietary Semi-Permeable Capsule technology is a versatile and highly scalable solution that enables multi-modal assays – starting with DNA and RNA together – in thousands to millions of individual cells per experiment.
Rapolas Žilionis, PhD, Chief Scientific Officer at Atrandi Biosciences